Naslov
Multiple paradoxical embolisms in patient with patent foramen ovale – case report

Autori
Trbušić, Matias ; Degoricija, Vesna ; Štambuk, Krešimir ; Dumančić, Jelena ; Gabrić, Ivo Darko ; Planinc, Danijel

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
7th National Meeting on Interventional Cardiology (Crointervent): abstracts, Cardiologia Croatica vol. 11(3/4) / Miličić, Davor ; Ivanuša, Mario ; Čikeš, Maja - Zagreb : Hrvatsko kardiološko društvo, 2016, 139-139

Skup
7th National Meeting on Interventional Cardiology 2016

Mjesto i datum
Zagreb, Hrvatska, 10.03.2016. - 12.03.2016

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
patent foramen ovale ; paradoxical embolism ; percutaneous patent foramen ovale closure

Sažetak
The diagnosis of paradoxical thromboembolism (PT) is based on the triad: venous thromboembolism, systemic arterial embolism in the absence of intracardiac thrombus, and intracardiac defect, usually a patent foramen ovale (PFO).1 We present a case of 54-year-old patient who complained of chest pain and shortness of breath. MDCT angiography showed massive pulmonary embolism (PE) and infarction of left kidney while Doppler showed deep vein thrombosis (DVT) of the right popliteal vein. Due to patients’ high weight (BMI 46.6 kg/m2 ), therapy with unfractionated heparin was started. Transthoracic echocardiography showed pulmonary hypertension and no intracardiac thrombus or tumors. During the next 24 hours the patient developed thromboembolic occlusion of right axillary artery and the urgent embolectomy was done. After 48 hours, the patient reported severe pain in the right lumbar region and right leg. MDCT angiography revealed right renal artery and the Doppler right femoral artery thromboembolism (second embolectomy was performed). Contrast enhanced transesophageal echocardiography (TEE) revealed tunnel-type PFO and spontaneous right to left flow. Because of repetitive PT despite optimal heparin therapy a temporary vena cava filter (VCF) was placed. The patient was further with no signs of re-embolism (discharged with warfarin). It was proven that the he has positive PAI-1 gene 4G/4G mutation. Two and a half months after the first hospitalization the temporary vena cava filter was removed. Due to the genetic thrombophilia, large PFO and spontaneous right-left flow, a decision was made to perform a percutaneous PFO closure with Amplatzer occluder device. In conclusion: if the arterial thromboembolism occurs in the settings of DVT and PE contrast enhanced TEE must be done as soon as possible owing to high sensitivity and specificity in detection of PFO and other intracardial shunts and masses.2 This seems to be especially important if the patient has proven thrombophilia. Temporary VCF is an unavoidable option if the patient has repetitive PE or arterial thromboembolism. Percutaneous closure of PFO (together with lifelong anticoagulation therapy) was the definite treatment in our patient despite the unfavorable results in studies for secondary prevention of cryptogenic embolism.3

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA